Telbivudine: all 50 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus InfectionTerminatedNCT02058108Phase 3Results posted
• Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap ConceptCompletedNCT01379508Phase 4Results posted
• Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHBCompletedNCT00805675Phase 3Results posted
• Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)TerminatedNCT00412750Phase 3Results posted
• Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedNCT00412529Phase 3Results posted
• Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir AloneTerminatedNCT00376259Phase 3Results posted
• Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine StudiesCompletedNCT00142298Phase 3Results posted
• Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of CirrhosisCompletedNCT00076336Phase 3Results posted
• Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
• The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedNCT03468907Phase 4
• Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.TerminatedNCT02894554Phase 4
• EFFORT Further Extension StudyStatus unknownNCT02826070Phase 4
• Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis BStatus unknownNCT02774837Phase 4
• Replacement of Lamivudine by Telbivudine to Improve Renal FunctionCompletedNCT02447705Phase 2/3
• TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionCompletedNCT02338674Phase 1/2
• Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal DiseasesWithdrawnNCT02049736Not applicable
• Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot StudyStatus unknownNCT01804387Phase 4
• Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled TrialStatus unknownNCT01799486Phase 4
• Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B VirusCompletedNCT01788371Phase 4
• Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis BCompletedNCT01743079Phase 4
• Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBVCompletedNCT01637844Phase 4
• Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis BCompletedNCT01595685Phase 3
• Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With EntecavirStatus unknownNCT01588912Phase 4
• EFFORT Extension StudyStatus unknownNCT01529255Phase 4
• A Two-year Study of Telbivudine in HBeAg Negative HepatitisCompletedNCT01521975Phase 4
• Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)Status unknownNCT01380951Phase 4
• Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BStatus unknownNCT01270165Phase 3
• Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B PatientsWithdrawnNCT01260610Not applicable
• Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) TherapyStatus unknownNCT01102335Phase 4
• EFFicacy Optimization Research of Telbivudine TherapyCompletedNCT00962533Phase 4
• Efficacy and Safety Study of Telbivudine to Prevent Perinatal TransmissionStatus unknownNCT00939068Phase 4
• Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BCompletedNCT00907894Phase 1
• Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis BCompletedNCT00877149Phase 4
• Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV InfectionStatus unknownNCT00810524Phase 4
• Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)CompletedNCT00804622Phase 2
• Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis BCompletedNCT00781105Phase 4
• Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis BWithdrawnNCT00710216Phase 4
• Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis BCompletedNCT00646503Phase 4
• Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineCompletedNCT00640588Phase 3
• Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWithdrawnNCT00606099Phase 4
• To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)CompletedNCT00537537Phase 4
• An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedNCT00467545Phase 4
• Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
• A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.CompletedNCT00275652Phase 3
• Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
• Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
• Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis BCompletedNCT00128544Phase 2
• An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2
• Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
• Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIVWithdrawnNCT00051090Not applicable

← Telbivudine overview